S A Cannistra
Overview
    Explore the profile of S A Cannistra including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              65
            
            
              Citations
              1285
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Comander A, Cannistra S
  
  
    Int J Gynecol Cancer
    . 2007 May;
          18(1):51-8.
    
    PMID: 17506844
  
  
          To determine the tolerability of oral maintenance topotecan when administered to patients with advanced ovarian, fallopian tube, and primary peritoneal serous cancers who have achieved a complete clinical response after...
      
2.
        
    
    Raffel G, Gravallese E, Schwab P, Joseph J, Cannistra S
  
  
    J Clin Oncol
    . 2001 Dec;
          19(23):4341-3.
    
    PMID: 11731518
  
  
          No abstract available.
      
3.
        
    
    Smith W, Zhou X, Kurose K, Gao X, Latif F, Kroll T, et al.
  
  
    Hum Genet
    . 2001 Aug;
          109(2):146-51.
    
    PMID: 11511919
  
  
          Peroxisome proliferator activated receptor gamma (PPARgamma) is a nuclear hormone receptor that has been shown to regulate differentiation and cell growth. Studies of the differentiative effects of PPARgamma agonists on...
      
4.
        
    
    Kurose K, Zhou X, Araki T, Cannistra S, Maher E, Eng C
  
  
    Am J Pathol
    . 2001 Jun;
          158(6):2097-106.
    
    PMID: 11395387
  
  
          PTEN (MMAC1/TEP1), a tumor suppressor gene on chromosome subband 10q23.3, is variably mutated and/or deleted in a variety of human cancers. Germline mutations in PTEN, which encode a dual-specificity phosphatase,...
      
5.
        
                      6.
        
    
    Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, et al.
  
  
    Gynecol Oncol
    . 2000 Apr;
          77(2):271-7.
    
    PMID: 10785477
  
  
          Objectives: The goal of this study was to determine the maximally tolerated doses (MTDs) of carboplatin, paclitaxel (Taxol), etoposide, and cyclophosphamide (CTEC) with granulocyte-colony stimulating factor (G-CSF, Filgrastim) support as...
      
7.
        
    
    Strobel T, Cannistra S
  
  
    Gynecol Oncol
    . 1999 Jun;
          73(3):362-7.
    
    PMID: 10366461
  
  
          Ovarian cancer cells frequently metastasize by implanting onto the peritoneal mesothelial surface of the abdominal cavity. Although the CD44 molecule expressed by ovarian cancer cells is known to partly mediate...
      
8.
        
    
    Tai Y, Strobel T, Kufe D, Cannistra S
  
  
    Cancer Res
    . 1999 May;
          59(9):2121-6.
    
    PMID: 10232598
  
  
          The BAX proapoptotic protein is capable of inducing cell death either directly, through its effects on mitochondrial function, or indirectly, by lowering the apoptotic threshold in response to certain chemotherapy...
      
9.
        
                      10.
        
    
    Strobel T, Tai Y, Korsmeyer S, Cannistra S
  
  
    Oncogene
    . 1998 Nov;
          17(19):2419-27.
    
    PMID: 9824152
  
  
          Although paclitaxel is an important chemotherapy agent for the treatment of patients with epithelial ovarian cancer, its utility is significantly limited by the frequent development of drug resistance. Recent evidence...